Lecture Will Focus on Future Medical Technology

Full access

Daniel Kraft, MD

Citation: Kidney News 13, 10/11

A physician-scientist, inventor, and entrepreneur will deliver a state-of-the-art lecture titled “The Future of Health and Medicine: Where Can Technology Take Us?” on Saturday, November 6.

Daniel Kraft, MD, has served as the Chair for Medicine and Neuroscience at Singularity University since its inception in 2008. Singularity University describes itself as a global community using exponential technologies to tackle the world's biggest challenges. In 2011, Dr. Kraft founded the Exponential Medicine Program there, which explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

Dr. Kraft currently chairs the XPRIZE Pandemic Alliance Task Force, a group of more than 60 leading universities, nongovernment organizations, and corporations focused on catalyzing medical solutions.

With more than 25 years of experience in clinical practice, biomedical research, and healthcare innovation, he is often called upon to speak on the future of health, medicine, and technology and has given five TED and TEDMED talks. He has many scientific publications and medical device, immunology, and stem cell-related patents through faculty positions with the Stanford University School of Medicine and as clinical faculty for the Pediatric Bone Marrow Transplantation Service at the University of California San Francisco.

Dr. Kraft's academic research has focused on stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T cell differentiation, and humanized animal models. His research has been published in journals that include Nature and Science.

His clinical work focuses on bone marrow and hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, as well as medical devices to enable stem cell-based regenerative medicine, including marrow-derived stem cell harvesting, processing, and delivery. He invented the MarrowMiner, a US Food and Drug Administration-approved device for the minimally invasive harvesting of bone marrow, and founded RegenMed Systems, a company developing regenerative therapies based on adult stem cell technologies.

Dr. Kraft implemented the first text-paging system at Stanford Hospital and advises several digital health-related startups. He recently founded IntelliMedicine, a startup focused on personalized, data-driven, precision medicine.

He is an avid pilot and has served in the Massachusetts and California Air National Guards as a flight surgeon with F-15 and F-16 fighter squadrons. He has conducted research on aerospace medicine that was published with NASA, with which he was a finalist for astronaut selection.

Following medical school at Stanford, Dr. Kraft was board certified in internal medicine and pediatrics after completing a residency at Massachusetts General Hospital and Boston Children's Hospital. He then completed fellowships in hematology, oncology, and bone marrow transplantation at Stanford. He is a member of the inaugural class of the Aspen Institute Health Innovators Fellowship.